Yi-Hung Ou

Yi-Hung Ou

UNVERIFIED PROFILE

Are you Yi-Hung Ou?   Register this Author

Register author
Yi-Hung Ou

Yi-Hung Ou

Publications by authors named "Yi-Hung Ou"

Are you Yi-Hung Ou?   Register this Author

12Publications

286Reads

14Profile Views

Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B.

Nat Chem Biol 2015 Jun 13;11(6):401-8. Epub 2015 Apr 13.

Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nchembio.1797DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433765PMC
June 2015

Degradation of AMPK by a cancer-specific ubiquitin ligase.

Cell 2015 Feb;160(4):715-728

Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Departments of Pharmacology and Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2015.01.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629913PMC
February 2015

The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.

EMBO J 2007 Sep 9;26(17):3968-80. Epub 2007 Aug 9.

Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.emboj.7601825DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994125PMC
September 2007

TTK/hMps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68.

J Biol Chem 2005 Mar 23;280(9):7748-57. Epub 2004 Dec 23.

Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M410152200DOI Listing
March 2005